PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

55 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... 3 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
1.
Gschwendtner, S. et al.: Longitudinal dynamics and site-specific recovery of the human respiratory microbiome following smoking cessation. Respir. Res. 27:163 (2026)
2.
Lagally, L.* et al.: Increased high sensitivity C-reactive protein in more severe wheeze/asthma phenotypes in child- and adulthood in ALLIANCE. Respir. Res. 27, 14:294 (2026)
3.
Diallo, T.D.* et al.: Paraspinal myosteatosis is associated with COPD: A cross-sectional MRI analysis from the population-based KORA cohort. Respir. Res. 26:217 (2025)
4.
Melo-Narváez, M.C et al.: Cold storage of human precision-cut lung slices in TiProtec preserves cellular composition and transcriptional responses and enables on-demand mechanistic studies. Respir. Res. 26:57 (2025)
5.
Buschulte, K.* et al.: Hospitalisation patterns in interstitial lung diseases: Data from the EXCITING-ILD registry. Respir. Res. 25:5 (2024)
6.
Buschulte, K.* et al.: Disease trajectories in interstitial lung diseases - data from the EXCITING-ILD registry. Respir. Res. 25:113 (2024)
7.
Upadhyay, S.* et al.: Assessment of wood smoke induced pulmonary toxicity in normal- and chronic bronchitis-like bronchial and alveolar lung mucosa models at air-liquid interface. Respir. Res. 25:49 (2024)
8.
Pouwels, S.D.* et al.: Smoking increases expression of the SARS-CoV-2 spike protein-binding long ACE2 isoform in bronchial epithelium. Respir. Res. 24:130 (2023)
9.
Staude, B.* et al.: Microbial signatures in amniotic fluid at preterm birth and association with bronchopulmonary dysplasia. Respir. Res. 24:248 (2023)
10.
Kreuter, M.* et al.: Epidemiology, healthcare utilization, and related costs among patients with IPF: Results from a German claims database analysis. Respir. Res. 23:62 (2022)
11.
Marijic, P. et al.: Comparing outcomes of ILD patients managed in specialised versus non-specialised centres. Respir. Res. 23:220 (2022)
12.
Nikolova, S.* et al.: Correction to: Phosphodiesterase 6 subunits are expressed and altered in idiopathic pulmonary fibrosis. Respir. Res. 23:2 (2022)
13.
van der Does, A.M.* et al.: Early transcriptional responses of bronchial epithelial cells to whole cigarette smoke mirror those of in-vivo exposed human bronchial mucosa. Respir. Res. 23:227 (2022)
14.
Huber, M.B. et al.: Long-term weight gain in obese COPD patients participating in a disease management program: A risk factor for reduced health-related quality of life. Respir. Res. 22:226 (2021)
15.
Kellerer, C.* et al.: Prediction of lung emphysema in COPD by spirometry and clinical symptoms: Results from COSYCONET. Respir. Res. 22:242 (2021)
16.
Maqhuzu, P.N. et al.: Cost drivers in the pharmacological treatment of interstitial lung disease. Respir. Res. 22:218 (2021)
17.
Marijic, P. et al.: Pirfenidone vs. nintedanib in patients with idiopathic pulmonary fibrosis: A retrospective cohort study. Respir. Res. 22:268 (2021)
18.
Huber, M.B. et al.: The relationship between body mass index and health-related quality of life in COPD: Real-world evidence based on claims and survey data. Respir. Res. 21:291 (2020)
19.
Kahnert, K.* et al.: The impact of COPD on polyneuropathy: Results from the German COPD cohort COSYCONET. Respir. Res. 21:28 (2020)
20.
Veit, T. et al.: Variability of forced vital capacity in progressive interstitial lung disease: A prospective observational study. Respir. Res. 21:270 (2020)
▮◀ ◀◀ 1 ... 2 ... 3 ... ▶▶ ▶▮